Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01919853 · ClinicalTrials.gov registry record · NA

Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
107
Enrollment target

NCT01919853 is a NA study that has completed, run by Indiana University. The registered enrollment target is 107 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01919853, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effects of Mindfulness-Based Stress Reduction (MBSR) to an attention control psycho-educational support group in treating cancer-related fatigue (CRF) in early-stage (0-III) post-treatment cancer survivors with clinically-significant CRF. The study will collect, store, and later analyze blood and urine samples for several biomarkers that may be linked to persistent CRF in cancer survivors.

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Mindfulness-Based Stress Reduction

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2012-09
Est. Completion 2013-11
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT01919853

The ClinicalTrials.gov registry entry for NCT01919853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.

NCT01919853 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01919853 about?

NCT01919853 is a clinical study titled "Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response". The purpose of this study is to compare the effects of Mindfulness-Based Stress Reduction (MBSR) to an attention control psycho-educational support group in treating cancer-related fatigue (CRF) in early-stage (0-III) post-treatment cancer survivors with clinically-significant CRF. The study will co...

What is the current status of trial NCT01919853?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2012-09. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01919853?

The interventions under investigation include: Attention Control (BEHAVIORAL), Mindfulness-Based Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01919853?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.